Sonic Healthcare Limited (FRA:SAB)
Germany · Delayed Price · Currency is EUR 13.13
-0.21 (-1.54%)
At close: Jan 28, 2026
Sonic Healthcare Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 513.6 | 511.09 | 684.98 | 1,461 | 1,315 |
Depreciation & Amortization | 723.39 | 696.45 | 632.83 | 608.51 | 574.47 |
Other Amortization | 91.97 | 80.86 | 70.1 | 66.91 | 67.12 |
Other Operating Activities | 59.18 | -8.18 | 42.41 | 63.95 | 86.2 |
Change in Accounts Receivable | -66.94 | -207.84 | 244.26 | -83.02 | - |
Change in Inventory | -4.51 | -0.02 | 27.47 | 9.88 | - |
Change in Accounts Payable | -17.75 | 205.95 | -128.82 | -42.55 | - |
Change in Income Taxes | -16.49 | -187.91 | -165.2 | 123.55 | - |
Change in Other Net Operating Assets | -18.82 | -61.6 | 9.74 | -41.81 | - |
Operating Cash Flow | 1,297 | 1,072 | 1,471 | 2,226 | 2,043 |
Operating Cash Flow Growth | 21.02% | -27.16% | -33.91% | 8.96% | 50.18% |
Capital Expenditures | -336.24 | -470.61 | -389.13 | -286.95 | -273.58 |
Cash Acquisitions | -94.57 | -1,346 | -82.39 | -547.16 | -31.6 |
Divestitures | - | - | - | - | 24.4 |
Sale (Purchase) of Intangibles | -126.45 | -108.89 | -107.89 | -91.64 | -89.61 |
Investment in Securities | -35.7 | -40.21 | -27.53 | -81.21 | -20.92 |
Other Investing Activities | 5.83 | 150.55 | 15.2 | 14.99 | - |
Investing Cash Flow | -577.62 | -1,805 | -580.04 | -989.18 | -386.75 |
Long-Term Debt Issued | 2,046 | 2,092 | 116.11 | 137.84 | 122.44 |
Long-Term Debt Repaid | -2,215 | -1,135 | -490.42 | -762.53 | -1,705 |
Net Debt Issued (Repaid) | -169.32 | 957.34 | -374.31 | -624.69 | -1,582 |
Issuance of Common Stock | - | 204.41 | 84.27 | 48.82 | 53.96 |
Repurchase of Common Stock | - | -10 | -130.93 | -302.55 | -0.33 |
Common Dividends Paid | -514.03 | -499.41 | -480.35 | -455.4 | -415.51 |
Other Financing Activities | -52.57 | -59.93 | -10.18 | -15.47 | -10.72 |
Financing Cash Flow | -735.93 | 592.41 | -911.51 | -1,349 | -1,955 |
Foreign Exchange Rate Adjustments | 45.53 | -11.47 | 38.52 | -7.18 | -31.75 |
Net Cash Flow | 28.77 | -152.99 | 18 | -119.83 | -330.32 |
Free Cash Flow | 960.55 | 600.9 | 1,082 | 1,939 | 1,769 |
Free Cash Flow Growth | 59.85% | -44.46% | -44.20% | 9.59% | 57.21% |
Free Cash Flow Margin | 9.96% | 6.70% | 13.24% | 20.76% | 20.21% |
Free Cash Flow Per Share | 2.00 | 1.26 | 2.29 | 4.01 | 3.67 |
Cash Interest Paid | 168.7 | 145.49 | 83.75 | 76.96 | 102.84 |
Cash Income Tax Paid | 170.9 | 329.67 | 339.99 | 378.19 | 342.22 |
Levered Free Cash Flow | 725.2 | 418.2 | 786.04 | 1,548 | 1,533 |
Unlevered Free Cash Flow | 838.02 | 512.79 | 840.43 | 1,598 | 1,591 |
Change in Working Capital | -91.35 | -208.7 | 40.71 | 25.89 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.